The CDC’s primary medical journal for disseminating public health information went unpublished this week — seemingly for the ...

Clindamycin phosphate 1.2%, adapalene 0.15% and benzoyl peroxide 3.1% triple-combination topical surpassed dyad formulations ...

In this Healio Video Perspective from Retina 2025, Peter K. Kaiser, MD, of Ocular Therapeutix, discusses positive data for ...

The allergy and immunology community mourns the loss of Marcus Maurer, MD, executive director of the Institute of Allergology ...

Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses recent breakthroughs demonstrating that gene ...

Retina specialists have a lot of options when it comes to intravitreal injection procedures, according to a speaker at Retina ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

Some social determinants of health act as barriers to maintaining a healthy diet during pregnancy and higher saturated fats ...

Few researchers can claim to be a pioneer in their field quite like Teresa K. Woodruff, PhD. While serving as the basic ...